XML 18 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current Assets    
Cash $ 17,414,237 $ 9,179,075
Accounts receivable, net 1,612,308 648,421
Product deposit 1,391,764 816,765
Inventory, net 1,614,117 1,264,258
Other current assets 447,233 154,876
Total Current Assets 22,479,659 12,063,395
Non-current Assets    
Equipment, net 18,116
Right of use asset, net 225,259 274,437
Capitalized software, net 1,264,466 375,983
Intangible assets, net 339,840
 Total Non-current Assets 1,507,841 990,260
Total Assets 23,987,500 13,053,655
Current Liabilities    
Accounts payable and accrued expenses 16,726,698 11,794,084
Notes payable, net 438,234 779,132
Deferred revenue 1,381,938 916,880
Total Current Liabilities 18,546,870 13,490,096
Long-term Liabilities    
Long-term debt 9,251,849
Lease liability 240,670 285,323
Contingent consideration on purchase of LegalSimpli 100,000 100,000
Total Liabilities 28,139,389 13,875,419
Commitments and contingencies (see Note 8)
Stockholders’ Deficit    
Common stock, $0.01 par value; 100,000,000 shares authorized, 26,635,840 and 23,433,663 shares issued, 26,532,800 and 23,330,623 outstanding as of June 30, 2021 and December 31, 2020, respectively 266,359 234,337
Additional paid-in capital 101,450,858 77,779,370
Accumulated deficit (108,584,988) (80,151,905)
Treasury stock, 103,040 and 103,040 shares, at cost (163,701) (163,701)
Total LifeMD, Inc. Stockholders’ Deficit (7,031,472) (2,301,899)
Non-controlling interest (1,001,869) (2,175,687)
Total Stockholders’ Deficit (8,033,341) (4,477,586)
Total Liabilities, Mezzanine Equity and Stockholders’ Deficit 23,987,500 13,053,655
Series B Preferred Stock [Member]    
Mezzanine Equity    
Preferred Stock Value $ 3,881,452 $ 3,655,822